European Journal of Surgical Oncology
Volume 33 , Pages S88-S94 , December 2007

Factors that influence treatment strategies in advanced colorectal cancer

  • C. Nesbitt
    • ,
  • R.J. Glendinning
    • ,
  • C. Byrne
    • ,
  • G.J. Poston

      Affiliations

    • Corresponding Author InformationCorresponding author: Department of Surgery, Liverpool Supra-Regional Hepatobiliary Centre, University Hospital Aintree, Lower Lane, Liverpool L9 7AL, UK. Tel.: +44 0151 529 8578; fax: +44 0151 529 8547.

,Accepted 26 September 2007.

References 

  1. Poston GJ. Surgical strategies for colorectal liver metastases. Surg Oncol. 2004;13:125–136
  2. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994;343:1405–1410
  3. Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg. 1999;86:158–169
  4. Sahani DV, Kalva SP. Imaging the liver. Oncologist. 2004;9:385–397
  5. McLoughlin JM, Jensen EH, Malafa M. Resection of colorectal liver metastases. Cancer Control. 2006;13:32–41
  6. Vauthey JN. Patients with hepatic colorectal metastases. Program of the AHPBA 2006 consensus conference. San Francisco: California; January 25, 2006;
  7. Saini S. Imaging of hepatobiliary tract. N Engl J Med. 1997;336:1889–1894
  8. Charnsangavej C. Selection for resection: preoperative imaging evaluation. Program of the AHPBA 2006 consensus conference. San Francisco: California; January 25, 2006;
  9. Israel O, Mor M, Gaitini D, et al. Combined structural and functional evaluation of cancer patients with a hybrid camera based PET/CT system using (18) F-FDG. J Nucl Med. 2002;43:1129–1136
  10. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94:982–999
  11. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986;100:278–284
  12. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–318
  13. Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg. 2000;231:487–499
  14. Vauthey JN, Pawlik TM, Abdalla EK, et al. Is extended hepatectomy for hepatobiliary malignancy justified?. Ann Surg. 2004;239:722–732
  15. Scheele J, Stangl R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg. 1995;19:59–71
  16. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–724
  17. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644–657
  18. Petrowsky H, Gonen M, Jarnagin W, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg. 2002;235:863–871
  19. Kanemitsu Y, Kato T, Hirai T, Yasui K. Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg. 2004;91:112–120
  20. Pozzo C, Basso M, Cassano A, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol. 2004;15:933–939
  21. Fong Y, Bentrem DJ. CASH (Chemotherapy-Associated Steatohepatitis) costs. Ann Surg. 2006;243:8–9
  22. Poston GJ, Byrne C. Decision making for patients with colorectal cancer liver metastases. Ann Surg Oncol. 2006;13:10–11
  23. Bilchik AJ, Poston G, Curley SA, et al. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol. 2005;23:9073–9078
  24. Karoui M, Penna C, Amin-Hashem M. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006;243:1–7
  25. Feliberti EC, Wagman LD. Radiofrequency ablation of liver metastases from colorectal cancer. Cancer Control. 2006;13:48–51
  26. Primrose JN. Treatment of colorectal metastases: surgery, cryotherapy or radiofrequency ablation. Gut. 2002;50:1–5
  27. Poston GJ. Radiofrequency ablation of colorectal liver metastases: where are we really going?. J Clin Oncol. 2005;23:1342–1344
  28. Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumors. Br J Surg. 2002;89:1206–1222
  29. Curley SA, Marra P, Beaty KPA-C, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004;239:450–458
  30. AJCC . AJCC cancer staging manual. 6th ed.. New York: Springer Verlag; 2002;
  31. Poston GJ, Adam R, Vauthey J-N. Comments and controversies: ‘Downstaging’ or ‘downsizing’: time for a new staging system in advanced colorectal cancer?. J Clin Oncol. 2006;24:2702–2706
  32. Van Cutsem E, Adam R, Rougier P, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer. 2006;42:2212–2221
  33. Poston GJ, Adam R, Alberts S, et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol. 2005;23:7125–7134
  34. Martin RCG, Studts JL, McGuffin SA, et al. Method of presenting oncology treatment outcomes influences patient treatment decision-making in metastatic colorectal cancer. Ann Surg Oncol. 2006;13:86–95
  35. Faulkner A, Maguire P. Talking to cancer patients and their relatives. Oxford Medical Publications; 1994;
  36. Sanders T, Skevington S. Participation as an expression of patient uncertainty: an exploration of bowel cancer consultations. Psycho-oncology. 2004;13:675–688
  37. Beaver K, Bogg J, Luker KA. Decision making role preferences and information needs: a comparison of colorectal and breast cancer. Health Expect. 1999;2:266–276
  38. Beaver K, Jones D, Susnerwala S, et al. Exploring decision making preferences of people with colorectal cancer. Health Expect. 2005;8:103–113
  39. Wright JR, Whelan TJ, Schiff S, et al. Why cancer patients enter randomised clinical trials: exploring the factors that influence their decision. J Clin Oncol. 2004;22(43):12–18
  40. Dowsett SM, Saul JL, Butow PN, et al. Communication style in the cancer consultation: preferences for a patient-centred approach. Psycho-oncology. 2000;9:147–156
  41. Coulter A. Paternalism or partnership? Patients have grown-up and there's no going back. BMJ. 1999;319:719–720
  42. Maguire P, Faulkner A, Booth K, et al. Helping cancer patients disclose their concerns. Eur J Cancer. 1996;32A:78–81
  43. Heaven CM, Maguire P. Training hospice nurses to elicit patient concerns. J Adv Nurs. 1996;23:280–286
  44. Razavi D, Dlavaux N, Marchal S, De Cock M, Farvaques C, Slachmuylder J-L. Psycho-oncology. 2000;9:293–302
  45. Fallowfield L, Jenkins V, Farewell V, Saul J, Duffy A, Eves R. Efficacy of a cancer research UK communication skills training model for oncologists: a randomised controlled trial. Lancet. 2002;359:650–656
  46. Booth K, Maguire P, Butterworth T, Hillier VF. Perceived professional support and the use of blocking behaviours by hospice nurses. J Adv Nurs. 1996;24:522–527
  47. Maguire P. Breaking bad news. Eur J Surg Oncol. 1998;24:188–191

PII: S0748-7983(07)00555-0

doi: 10.1016/j.ejso.2007.09.019

European Journal of Surgical Oncology
Volume 33 , Pages S88-S94 , December 2007

Article Tools